Ciclesonide Appears No Better Than Placebo In Alleviating COVID-19-Related Symptoms Among Nonhospitalized Patients In Trial

Healio (11/22, Miller) reports, “Nonhospitalized patients with COVID-19 who received the inhaled glucocorticoid [ciclesonide] Alvesco had the same recovery time as those who received placebo, data from a phase 3 trial showed.” According to investigators,...